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Endometriosis is a common gynecological disease that affects up to 10% of women in their reproductive years. It
causes pelvic pain, severe dysmenorrhea, and subfertility. The disease is defined as the presence of tissue resembling
endometrium in sites outside the uterus. Its cause remains uncertain despite 150 years of hypothesis-driven research,
and thus the therapeutic options are limited. Disease predisposition is inherited as a complex genetic trait, which
provides an alternative route to understanding the disease. We seek to identify susceptibility loci, using a positional-
cloning approach that starts with linkage analysis to identify genomic regions likely to harbor these genes. We
conducted a linkage study of 1,176 families (931 from an Australian group and 245 from a U.K. group), each
with at least two members—mainly affected sister pairs—with surgically diagnosed disease. We have identified a
region of significant linkage on chromosome 10q26 (maximum LOD score [MLS] of 3.09; genomewide Pp .047)
and another region of suggestive linkage on chromosome 20p13 (MLS p 2.09). Minor peaks (with MLS 1 1.0)
were found on chromosomes 2, 6, 7, 8, 12, 14, 15, and 17. This is the first report of linkage to a major locus for
endometriosis. The findings will facilitate discovery of novel positional genetic variants that influence the risk of
developing this debilitating disease. Greater understanding of the aberrant cellular and molecular mechanisms
involved in the etiology and pathophysiology of endometriosis should lead to better diagnostic methods and targeted
treatments.
Introduction
Endometriosis (MIM 131200) is a common gynecolog-
ical disease that causes pelvic pain, severe dysmenorrhea
(painful periods), and subfertility. It is defined as the
presence of tissue resembling endometrium in sites out-
side the uterus, most commonly the pelvic peritoneum,
ovaries, and rectovaginal septum (Giudice and Kao
2004). The main pathological processes associated with
the disease are peritoneal inflammation and fibrosis and
the formation of adhesions and ovarian cysts.
The diagnosis is usually made by visual inspection of
the pelvis at laparoscopy, because noninvasive diagnos-
tic tools, such as ultrasound scanning, can reliably de-
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tect only severe forms of the disease—that is, ovarian
endometriotic cysts. Therefore, the population preva-
lence is difficult to measure. The best estimates indicate
that endometriosis affects 8%–10% of women in their
reproductive years (Eskenazi and Warner 1997), and it
has been suggested that, in North America alone, 15.5
million women are affected (National Institute of Child
Health and Human Development 2002). These data are
compatible with the prevalence estimate of 7.2% from
our own study of a large community sample of Aus-
tralian twins (Treloar et al. 1999).
The cause of endometriosis remains uncertain despite
150 years of hypothesis-driven research, and thus the
therapeutic options are limited. However, there is now
convincing evidence that the disease is inherited as a
complex genetic trait (Simpson and Bischoff 2002; Ken-
nedy 2003; Giudice and Kao 2004). Genetic factors
accounted for 52% of the variation in liability to endo-
metriosis in our Australian twin study (Treloar et al.
1999). Familial aggregation has been reported in hu-
mans (Kennedy et al. 1995; Stefansson et al. 2002) and
366 Am. J. Hum. Genet. 77:365–376, 2005
Table 1
Characteristics of Affected Women
in Combined Genome Scan Data
Characteristic Value
Age in 2002 (years):
Median 39
Range 15–87
No. (%) with disease:
Stage A (rAFS I–II) 1,550 (62)
Stage B (rAFS III–IV) 957 (38)
No. (%) with pelvic pain:
Yes 2,109 (79)
No 555 (21)
Age at symptom onset (years):
Median 19
Range 8–51
Age at diagnosis (years):
Median 28
Range 10–64
No. (%) with subfertility:
Any problem in conceiving 1,237 (48)
No problem in conceiving 902 (35)
Unknown/untested 456 (17)
NOTE.—In calculation of values, N ranged
from 2,516 to 2,696.
in nonhuman primates with spontaneous disease (Zon-
dervan et al. 2004). In an Icelandic population study,
the average kinship coefficient for the women identified
with endometriosis was significantly higher than that
calculated for 1,000 sets of 750 matched controls (Ste-
fansson et al. 2002). The genetic relative-recurrence risk
for sibs (ls) was estimated to be 2.34 in our Australian
sample of twins and their families (Treloar et al. 1999).
The most widely accepted theory to explain endo-
metriosis is that viable endometrial cells reach the peri-
toneal cavity through retrograde menstruation along
the fallopian tubes (Sampson 1927). Some cells then
adhere to the peritoneal surface and proliferate. How-
ever, it is well established that menstrual debris is pre-
sent in the peritoneal cavity of 90% of menstruating
women, suggesting that endometrial cells from only
some women are capable of establishing ectopic en-
dometrial implants. There are several possible expla-
nations for such susceptibility, including differences in
genetic predisposition, increased exposure to menstrual
debris, abnormal eutopic endometrium, altered peri-
toneal environment, reduced immune surveillance, and
increased angiogenic capacity (Healy et al. 1998; Vina-
tier et al. 2001; Treloar et al. 2002; Varma et al. 2004).
Various functional candidates have been tested for
association as disease-susceptibility genes, but many of
these case-control studies have lacked power and/or
adequate controls; the results have therefore been in-
conclusive (Zondervan et al. 2001). Several researchers
have adopted a positional-cloning approach to identify
loci for endometriosis (Kennedy 2003). One unpub-
lished study reported modest linkage to an unidentified
chromosome 10 candidate region in 32 Puerto Rican
families (Flores et al. 2004). Linkage to two candidate
genes—GSTM1 on chromosome 1p13 (Hadfield et al.
2001) and GALT (MIM 606999) on 9p13 (Stefansson
et al. 2001)—has been excluded, but no positive-linkage
regions from genomewide mapping have been reported
to date.
We recruited 11,000 families—mainly affected sister
pair (ASP) families—for a positional-cloning approach
in our International Endogene Study (Treloar et al.
2002), which resulted from the merger of two indepen-
dent groups: the Australian Genes Behind Endometri-
osis Study and the United Kingdom–based, interna-
tional Oxford Endometriosis Gene (OXEGENE) Study;
this ensured that the combined resource had 80% power
to detect loci of modest effect ( ) (Treloar et al.l  1.3s
2002), which is consistent with current expectations for
most complex diseases. Here, we report results from the
genomewide linkage scan in 1,176 families, one of the
largest ASP linkage studies conducted for any disease
to date.
Methods
Family and Sample Collection
From 1995 to 2002, the Australian and U.K. groups
recruited affected families with the use of protocols that
have been described in detail elsewhere (Treloar et al.
2002). All women classified as affected had surgically
confirmed endometriosis. In both studies, disease sever-
ity was assessed retrospectively from medical records
by use of the revised American Fertility Society (rAFS)
classification system (American Fertility Society 1985),
which assigns patients to one of four stages (I–IV) on
the basis of the extent of the disease and the associated
adhesions present. The study families mainly comprised
ASPs, although parents and other affected relatives were
also recruited. If one or both parents were unavailable,
sibs were recruited to increase the identity-by-descent
(IBD) information, but they were assigned “unknown”
disease status. There were three or more affected sisters
in 104 (9%) of the sibships, which added power for
linkage detection. The final data set comprised 1,176
families (931 from the Australia group and 245 from
the U.K. group), with 1,242 independent affected sib-
ships (i.e., a sibship of size S is equivalent to in-S 1
dependent sib pairs [Suarez and Hodge 1979]) that in-
cluded two or more siblings. The mean number of
affected family members in both Australian and U.K.
kindreds was 2.3. Their ethnic backgrounds were sim-
ilar, and 195% of subjects were white. Affected women
completed a questionnaire about their pain symptoms
and fertility history (table 1).
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Approval for obtainment of medical records and col-
lection of blood for DNA extraction and for all ques-
tionnaires and interview schedules was obtained from
the Human Research Ethics Committee of the Queens-
land Institute of Medical Research. In the United King-
dom, the study received approval from the regional
Multi-Centre Research Ethics Committee, from local re-
search ethics committees, and from collaborating centers
in Leuven and Dublin. All participants gave written in-
formed consent.
Blood Sample Collection and Storage
In both studies, DNA was extracted from peripheral
blood lymphocytes (Miller et al. 1988) or from buccal
swabs with the use of Microcon Centrifugal Filter De-
vices (Amicons) and was stored at 4C at a concentration
of 300–600 mg/ml.
Genome Scans
In total, 4,985 individuals were genotyped, including
2,709 women with endometriosis. The genome scans for
the Australian families were performed by the Australian
Genome Research Facility (Ewen et al. 2000) and by
Oxagen, United Kingdom. Both groups used the 400
dinucleotide microsatellite markers from Linkage Map-
ping Set version 2 (LMSV2 [PE Biosystems]) to provide
∼10-cM coverage of the genome on the autosomes and
the X chromosome. To save cost and time, the final 79
Australian families were genotyped using only the 113
markers on chromosomes 9, 10, 11, 19, 20, 21, 22, and
X. The U.K. study genotyped a small number of addi-
tional microsatellite markers from the ABI Prism LMS
HD5 set (Applied Biosystems).
At both sites, markers were amplified individually and
were later combined into appropriate electrophoretic
running panels, with up to 20 PCR products combined
for one panel of markers (LMSV2 [PE Biosystems]). The
pooled PCR products were electrophoresed through
polyacrylamide gels on a PE Biosystems 377 (Australia)
or 3700 (United Kingdom) Automated Sequencer, with
the use of the recommended gel conditions and run pro-
tocols. PstI–restriction-digested lambda-phage DNA la-
beled with 6-carboxy rhodamine (GS500-ROX [PE Bio-
systems]) was included in each lane as a size standard
(Ewen et al. 2000).
Combining Genotype Data from the Two Studies
Linkage analyses used allele frequencies calculated
from pedigree founders by use of Sib-Pair (Duffy 2001).
One approach to combining the data for common mark-
ers in different studies is to pool the genotypes, but doing
so for samples typed at different facilities can be prob-
lematic because of allele binning and frequency differ-
ences. To avoid such difficulties, markers common to
both studies were treated as different markers located
at almost the same location (0.01 cM between them),
which thereby kept the data from the two studies sep-
arate by a method we called “merging.” Hence, the sep-
arate allele frequencies were maintained—that is, allele
frequencies were based on the Australian sample for the
Australian pedigrees and were based on the U.K. sample
for the U.K. pedigrees. Analyses of the markers for one
chromosome with this merging method and with the
much more labor-intensive pooling of alleles between
studies produced near-identical linkage results, indicat-
ing that this is a valid approach.
Data Integrity
In both studies, sibling and family relationships were
confirmed using GRR (which gives a graphical repre-
sentation of relationships) (Abecasis et al. 2001). Data
were cleaned prior to analysis of Mendelian inconsis-
tencies with the use of Sib-Pair (Duffy 2001), PedCheck
(O’Connell and Weeks 1998), and MERLIN (Abecasis
et al. 2002). If a Mendelian inconsistency was detected,
data for that marker were dropped for all family mem-
bers. Two families common to both data sets (which
occured because the U.K. group recruited a small num-
ber of families in Australia) were removed from the Aus-
tralian data set prior to analysis of combined data.
Statistical Analysis
For linkage analyses, we used a version of GENE-
HUNTER (v2.1) (Kruglyak et al. 1996) recompiled to
handle the very large numbers of families. The statistic
chosen for the analysis was the “possible triangle” max-
imum LOD score (MLS) that restricts maximization to
the set of possible IBD-sharing probabilities for ASPs
(Holmans 1993), where sibships of size S were weighted
to be equivalent to independent sib pairs. ThisS 1
approach has been shown to be the most powerful use
of available data that maintained the correct type I error
rate (Suarez and Hodge 1979; Davis and Weeks 1997).
We opted for a nonparametric statistic because (1) there
was no a priori reason to assume a particular disease
model and (2) the assignment of the status “unaffected”
is problematic (because a surgical procedure is required
to exclude endometriosis). The MLS statistic was chosen
because it has more-consistent power across disease
models in ASP studies than do single-parameter statistics
such as the nonparametric linkage (NPL) score (Cordell
2004). However, the U.K. data set contained several non-
ASP affected relative pairs (ARPs). Huang and Vieland
(2001) recently showed that the possible triangle MLS
statistic is approximately equivalent to the ordinary
parametric heterogeneity LOD (HLOD) score under the
assumption of a simple recessive model (Huang and Vie-
land 2001). Therefore, we also compared results ob-
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tained from parametric HLOD scores calculated under
a simple (i.e., with no phenocopies) recessive mode of
inheritance (which yields HLOD-R scores) (Greenberg
et al. 1998), assuming 50% penetrance (Hodge et al.
1997). As recommended by Pal et al. (2001), we specified
a disease gene frequency of 0.1. The X chromosome was
analyzed using an earlier version of the GENEHUNTER
program (X-GENEHUNTER) because the chromosome
is not included in later versions. In the final analyses,
we used published deCODE map positions for micro-
satellite markers when available and used Marshfield
sex-averaged positions when deCODE positions were
not available.
In accordance with the now widely accepted practice
(Abecasis et al. 2004a, 2004b; Song et al. 2004) to ob-
tain empirical estimates of genomewide significance lev-
els, simulations were performed using the pedigree struc-
tures in the data set and any missing genotypes. These
simulations allow us to take account of uneven marker
spacing and informativeness (see the work of Kruglyak
and Daly [1998] for a discussion of the utility of em-
pirical significance levels in linkage analysis). Simula-
tions were run on the data prior to the addition of the
fine markers but after the addition of the last 79 families.
Data for 1,000 genome scans were generated using
MERLIN (Abecasis et al. 2002), under the assumption
of no susceptibility loci, and were analyzed using our
modified version of GENEHUNTER. The empirical sig-
nificance level of an MLS peak was then estimated by
counting the proportion of genome scans containing one
or more peaks of that size. The cutoff for suggestive
linkage ( ) was calculated as the mean of theMLSp 1.88
genomewide MLS from each genome scan, which de-
termines the maximum peak size expected once per ge-
nome scan by chance alone. The significant linkage
threshold ( ) was defined as the MLS oc-MLSp 3.08
curring with probability 0.05 in a genome scan (i.e., 50
peaks of equal or greater size observed in the 1,000
simulations).
Stratified analyses of the combined genome scan data
were performed for stage of disease, age at symptom
onset, age at surgical diagnosis, presence of pelvic pain,
and problems in conceiving (subfertility). The number
of affected women per family (zero, one, or more than
one) who had the more extreme phenotype was the gen-
eral criterion used to allocate families to one of three
strata. For stage of disease, the three disease-severity
strata were defined by the presence of zero, one, or more
than one individual per family who had stage B (rAFS
stages III–IV) endometriosis. Families were stratified by
age at onset and age at diagnosis by use of the thresholds
!20 years and !27 years of age, respectively. For sub-
fertility, the relevant subphenotype for defining three
strata was the reported lifetime history of any problem
in conceiving. Since pelvic pain was so prevalent, we
defined only two strata—zero or one family member and
two or more family members reporting pelvic pain. To
assess the significance of evidence for linkage in a phe-
notypic subset, compared with that in the entire sample,
we randomly chose from the total sample the same num-
ber of families (1,000 replicates) in the subset of interest
and calculated the MLS under the null hypothesis, which
is analogous to the empirical estimation of genomewide
significance levels.
Results
For the final merged Australian and U.K. data, the high-
est MLSs were on chromosome 10q (3.09 at D10S587)
and chromosome 20p (2.09 at D20S889/D20S116). In
our simulation study, 47 of the 1,000 replicates had
peaks 3.09, and 360 had peaks 2.09, which implied
significant linkage on chromosome 10 (genomewide em-
pirical ) and suggestive linkage on chromo-Pp .047
some 20. The linkage (MLS) peaks for all chromosomes
are shown in figure 1, and table 2 gives the positions
and nearest markers for all MLS peaks 1.0.
To better define these peaks, we genotyped four ad-
ditional markers under each of the chromosome 10 and
20 peaks in the Australian families. One of these mark-
ers (D20S116) had already been typed in the U.K. fam-
ilies. These markers changed the shape of the peaks but
had minimal effects on the peak MLS: it increased from
3.09 to 3.16 for chromosome 10 and decreased from
2.09 to 1.86 for chromosome 20. The MLS curves are
shown in figure 2. The summit for the chromosome 20
region moved marginally, from 8.49 cM to 12.09 cM,
and the location of the chromosome 10 peak shifted
from 145.44 cM to 148.75 cM—that is, from D10S587
toward D10S1656 in the telomeric direction. Both Aus-
tralian and U.K. families contributed to the chromo-
some 10 linkage, with respective peaks of MLSp 2.06
and MLS p 1.48 when data were analyzed separately
(fig. 3A). Both sets of families also contributed to the
chromosome 20 peak (fig. 3B). Additional markers are
shown in figures 2 and 3.
Given the large sample size from which our linkage
statistics were calculated, conversion of the distribution
of the likelihood-ratio test statistic of linkage versus no
linkage into a x2 distribution will be asymptotically
valid (Walling et al. 2000). An MLS of 1.0 (which is a
mixture of x2 distributions with 0, 1, and 2 df) corre-
sponds to an asymptotic (two-sided) x2 with a P value
of .05 (Nyholt 2000). The end points of the 95% CI
are calculated by finding the locations on either side of
the 148.75 cM peak on chromosome 10 that have an
MLS of 2.16 (i.e., 1.0 less than the peak at 3.16). On
the basis of our fine-mapping results, the 95% CI for
the peak at 148.75 cM spans 15 cM, from 139.49
(10q26.11) to 154.77 cM (10q23.33).
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Table 2
Chromosomal Regions with Multipoint MLS 1 in Genome Scan
Chromosomea
Position of Peak
(cM) MLS Closest Marker(s)
2 141.79 1.14 D2S2256, D2S112
6 92.11 1.63 D6S460
6 111.49 1.59 D6S434
6 140.80 1.65 D6S292, D6S308
7 7.44 1.00 D7S517
7 182.19 1.48 D7S2423
8 56.60 1.44 D8S1771, D8S505
8 127.84 1.22 D8S514
10 147.57 3.09 D10S587
12 66.12 1.06 D12S368
14 64.11 1.16 D14S63
15 45.69 1.29 D5S987
17 79.63 1.03 D17S787, D17S944
20 11.32 2.09 D20S889, D20S116
a For chromosomes 10 and 20, 1,176 pedigrees were included. For
the other chromosomes listed in this table, 1,097 pedigrees were
included.
Figure 1 Linkage (MLS) curves for all chromosomes in the combined data set, prior to inclusion of additional fine markers. This composite
figure shows relative chromosome lengths. The genetic map of each chromosome is shown on the X-axis, and the MLS is shown on the
Y-axis. Thresholds for significant ( ) and suggestive ( ) genomewide linkage are indicated by horizontal lines.MLSp 3.08 MLSp 1.88
Stratification by Subphenotypes
Families with no stage B disease and those with mul-
tiple stage B–affected members contributed to the chro-
mosome 10 peak (table 3). Other results of stratified
analyses for chromosomes 10 and 20 are shown in table
3. Except for families with two or more affected mem-
bers reporting pelvic pain, no subphenotype stratum
contributed disproportionally more to the chromosome
10 peak, and no particular strata contributed more to
the chromosome 20 peak. More specifically, the original
chromosome 10 peak MLS increased to 3.39 in the 817
families with more than one affected woman reporting
pelvic pain (see table 3). One thousand permutations
using subgroups of 817 families chosen at random pro-
duced 94 replicates with an MLS 3.39, suggesting
that this observation was most likely a chance finding
( ). Indeed, a difference in MLS of 0.3 is notPp .094
significant at the nominal level. Further, very fewP ! .05
families had no women reporting pelvic pain (Treloar et
al. 2002).
Conditional Linkage Results
Conditioning on status at the chromosome 10 peak
did not increase the evidence for linkage at the chro-
mosome 20 peak. In contrast, conditional analysis of a
subset of 530 families with positive allele sharing at the
chromosome 20 peak resulted in an increased MLS at
the chromosome 10 peak of 3.71, and this was consistent
between both the Australian and the U.K. data sets (see
fig. 4). Permutations using subgroups of 530 families
chosen at random produced only 28 of 1,000 replicates
with an MLS 3.71 ( ), suggesting that thisPp .028
observation may not be a chance finding. However, this
result should be interpreted with caution, given that we
investigated a large number of stratifications.
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Figure 2 Fine mapping of chromosome 10 peak (A) and chromosome 20 peak (B). Linkage (MLS) curves are presented for the chromosomes
before and after the addition of several markers, shown in different colors. Microsatellite markers are shown in genetic map order along the
X-axis, with positions given in cM (Haldane). The Y-axis represents the MLS.
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Figure 3 Study of origin strata at chromosome 10 peak (A) and chromosome 20 peak (B). Linkage (MLS) curves that include the fine
markers are presented for the Australian and U.K. studies separately and also for the combined data set. Microsatellite markers are shown in
genetic map order along the X-axis, with positions given in cM (Haldane). The Y-axis represents the MLS. A, Results show the increase in
MLS when the two data sets are combined.
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Table 3
Linkage Results for Phenotypic Strata of Families, Including Fine Marker Data
PHENOTYPE AND STRATAa
NO. OF
FAMILIES
MLSb
Chromosome 10
(at 148.75 cM)
Chromosome 20
(at 12.09 cM)
Stage B (III–IV) disease:
0 Members (stage A only) 436 1.43 1.23
1 Member 401 .31 .96
11 Member 329 1.82 .07
Age at onset !20 years:
0 Members 392 .92 .46
1 Member 461 1.98 1.16
2 Members 313 .47 .34
Age at diagnosis !27 years:
0 Members 410 2.30 1.20
1 Member 390 .51 1.45
2 Members 366 .71 .01
Pelvic pain:
0 or 1 Member 349 .17 1.65
2 Members 817 3.39 .68
Subfertility:
0 Members 323 .81 .86
1 Member 487 1.91 .45
2 Members 356 .57 .80
a Families were stratified by the no. of family members with the phenotype.
b 1,166 families were informative at these positions.
Discussion
We present results from the first large-scale genomewide
scan for loci influencing susceptibility to endometriosis,
which is a common disease affecting millions of women
worldwide. To the best of our knowledge, this data set
is the largest collection of ASPs assembled to study en-
dometriosis and is one of the largest family collections
for mapping disease genes for any complex trait. Anal-
ysis of our combined set of families identified significant
linkage ( ) to a novel susceptibility locus onMLSp 3.16
chromosome 10q26.
The magnitude of the linkage scores we report is con-
sistent with ls estimates predicted by our twin study
(Treloar et al. 1999) and with those thought to pertain
to most complex genetic diseases. Expected MLSs cal-
culated for 1,243 independent ASPs showed higher val-
ues for incremental increases in ls than those obtained.
For example, with the formula of Risch (1990) and with
the assumption of fully informative ASPs, the expected
MLS was 5.1 for a locus-specific ls value of 1.3; raising
the locus-specific ls value to 1.5 would yield an expected
MLS of 10.9. Estimating the locus-specific ls value from
the IBD-sharing probabilities at the chromosome 10
peak, we obtained a very modest value of 1.07. How-
ever, it is possible that this estimate is biased, and hence
unreliable, because of reported problems in estimating
locus-specific heritability from the peak of a variance-
components genomewide scan (Goring et al. 2001). Our
chromosome 10 data are consistent with inclusion of
dominance variance (i.e., interaction among alleles at a
locus) in the MLS model; the maximum-likelihood es-
timates of the probability of affected sibs sharing 0, 1,
and 2 alleles IBD are 0.233, 0.466, and 0.301, respec-
tively, which suggests some degree of recessivity of the
disease allele. Indeed, had we not allowed for domi-
nance variance, we would have had !1% power to de-
tect this locus under a purely additive model (Risch
1990).
The MLS statistic is approximately equivalent to the
ordinary HLOD score with the assumption of a simple
recessive model (Huang and Vieland 2001), which sug-
gests that the MLS allows for heterogeneity without
explicitly modeling for it. In our data, multipoint het-
erogeneity linkage analysis calculated under a simple
(i.e., with no phenocopies) recessive mode of inheri-
tance (Greenberg et al. 1998) with the assumption of
50% penetrance (Hodge et al. 1997) and a gene fre-
quency of 0.1 (as recommended by Pal et al. [2001]),
produced an HLOD-R of 3.58 at 148.75 cM (maximum
; 2 cM distal). However, heterogeneityHLOD-Rp 3.75
analysis under a simple dominant model with the as-
sumption of 50% penetrance and a gene frequency of
0.01 produced a maximum HLOD-D of 1.05 at 148.75
cM. These analyses add weight to the conclusion that
the chromosome 10q locus best fits a recessive mode of
inheritance.
The chromosome 10 peak MLS showed a steady and
generally consistent incremental increase with the ad-
dition of more data during the course of the study. Fam-
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Figure 4 Linkage in chromosome 10 conditional on linkage to chromosome 20. Chromosome 10 linkage curves are presented for families
showing linkage at the chromosome 20 peak. Curves show MLS results for families linked to the chromosome 20 peak in the two studies
separately and for all linked families. Microsatellite markers are shown in genetic map order along the X-axis, with positions given in cM
(Haldane). The Y-axis represents the MLS.
ilies with more than two affected members comprised
∼22% of the entire sample and contributed ∼28% of
the linkage signal. Thus, their inclusion did not explain
the linkage result. Indeed, both the chromosome 10q
and the chromosome 20p peaks diminished with the
addition of the final 79 Australian families. Prior to their
addition, the chromosome 10q MLS was 4.16 and the
chromosome 20p peak was 2.13. Although the 79 ad-
ditional Australian kindreds diminished both the chro-
mosome 10 and the chromosome 20 peaks, no system-
atic ascertainment bias can be identified. These kindreds
were not selected for any particular characteristic or for
having multiple family members. The mean number of
affected members was 2.3 for the original kindreds and
2.5 for the last 79 families added. Recruitment of many
of those 79 kindreds took longer to complete than that
of the other kindreds, for a variety of logistic reasons.
They therefore fell into the last batch to be sent for
genome scanning, and we did not have enough money
to complete the scan on all chromosomes. The clinical
profile of those families was very similar to that of ear-
lier recruits with regard to pelvic pain (80% vs. 77%),
but they had somewhat lower proportions of women
with stage B disease (28% vs. 34%) and women with
a history of subfertility (39% vs. 49%) than did the
previous combined family collection.
It clearly would be desirable to have our finding in-
dependently confirmed, but other groups may not have
the resources to achieve the sample size of the present
study for replication purposes. Although we had suffi-
cient power to detect linkage to loci with effect sizes as
low as , it is interesting that only one peakl p 1.3s
achieved genomewide significance ( ) in thisPp .047
large data set. To obtain one MLS of this magnitude
from 1,176 families suggests substantial genetic hetero-
geneity and/or that more than one disease entity exists,
as suggested elsewhere (Nisolle and Donnez 1997).
However, analysis based on alternative phenotypic in-
formation is problematic if the criteria for stratification
are unknown, and it must be conducted cautiously, since
power can be lost through multiple testing.
Chromosome 10q26 had already been implicated in
a candidate gene study that reported aberrant endo-
metrial EMX2 (MIM 600035) expression in women
with endometriosis (Daftary and Taylor 2004). EMX2
(10q26.1) is the gene for a transcription factor required
for reproductive-tract development, which maps to a
region of allelic deletion corresponding to a putative
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endometrial tumor suppressor at 10q26 (Peiffer et al.
1995; Peiffer-Schneider et al. 1998). Another candidate
gene in the region is PTEN (MIM 601728) (10q23.31),
which has been implicated in the malignant transfor-
mation of ovarian endometriosis (Bischoff and Simp-
son 2000; Sato et al. 2000). Although outside the re-
ported support interval, both EMX2 and PTEN fall
within our 99.9% CI. We are therefore planning to test
for association in large numbers of cases and controls
with the use of SNPs in these and other positional-
candidate genes. In the first instance, cases will be drawn
from ASPs who share two alleles or one allele, which
are identical by descent, under the peak (Fingerlin et al.
2004; Wicks et al. 2004), to enrich for genetic predis-
position at this locus and to remove genetic heteroge-
neity, and we will then conduct replication studies with
independent case-parents triads. Although the gene or
genes in this region are likely to comprise only a subset
of all genes influencing susceptibility to endometri-
osis, discovery of even one should lead to a clearer un-
derstanding of the aberrant cellular and molecular
mechanisms and to better diagnosis and more-targeted
treatment.
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